Year 2 efficacy results of 2 randomized controlled clinical …
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
Article, Chapter
Full text availability for this item
Journal:
OphthalmologyOpens in new Window
Coverage:
- 1995~present